miRNA-122 exerts its tumor suppressive effect by inhibiting cyclin G1, inhibiting the insulin-like growth factor 1 receptor pathway, inhibiting the expression of toll-like receptor 4 in tumor cells, etc. (37). The gene discussed is TLR4; the disease is neoplasm.